Clin2
NCT07543926Possibly a fitNot yet recruiting

Vitamin D injection for common warts

Common Warts (Verruca Vulgaris)

Treatments studied

Part of Infections, Skin clinical trials.

This study tests a new way to treat common warts by injecting vitamin D directly into the wart. It may help your immune system clear the warts with minimal side effects.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
70 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 18 years old
  • You have common warts that look typical and are confirmed by a doctor or dermoscopy
  • You have not used any wart treatment for at least one month before joining
  • You are able to have the wart or warts injected as part of the study
  • You do not have chronic health issues like diabetes, high blood pressure, autoimmune diseases, kidney or liver failure, or blood problems, and you do not have infections near the warts
  • You are not pregnant, breastfeeding, or allergic to vitamin D

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07448844Recruiting· Phase 4
Comparing vitamin D3 and acyclovir shots for skin warts

This trial tests two injected treatments (vitamin D3 or acyclovir) for common skin warts. The goal is to see which one works better for warts that are new or have not gone away with other treatments.

Rawalpindi, Punjab Province
NCT07246590Recruiting· Phase 3
Cantharidin treatment for common warts in children and adults

This trial tests a medication called cantharidin for treating common warts. It is for people age 2 and older who are generally healthy and have at least one common wart on the body (but not on palms, soles, face, or genitals). Participants cannot use other wart treatments during the study.

Saint Augustine, Florida
NCT07637734Recruiting· Phase 3
Cantharidin treatment for common warts

This trial tests a medicated liquid called cantharidin for treating common warts on the body (not on the face, soles, or private areas). The liquid is painted on by a doctor and later removed, and the goal is to see if it clears warts safely.

San Diego, California
NCT07457918Recruiting· Phase 3
Long-term safety of cantharidin gel for common warts

This study follows people who completed an earlier cantharidin trial to see how safe and effective the medicine is over a longer time. You may join if you still have treatable warts or finished the earlier study.

Saint Augustine, Florida
NCT06749665Not yet recruiting
Wart treatment with sclerotherapy and candida antigen

This study tests two treatments for common warts: sclerotherapy (injecting a solution into the wart to cut off its blood supply) and candida antigen (a yeast extract that boosts the immune system to fight the wart). It aims to see if these treatments are safe and effective.

Sohag
NCT07196670Not yet recruiting· Phase 4
Vitamin D or acyclovir injections for plantar warts

This study compares two injected treatments for plantar warts (warts on the soles of your feet): vitamin D and acyclovir, an antiviral medicine. The goal is to see which works better to clear the warts.

Hear when a new Common Warts (Verruca Vulgaris) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.